BACKGROUND: Multiple sclerosis (MS) has been associated with inflammation of the uveal tract, suggesting an immunological link between the uvea and central nervous system (CNS) in this disease. The retina is embryologically derived from the CNS, and it is conceivable that retinal antigens may also be recognized by the immune system in MS. Electroretinographic abnormalities, as well as retinal autoantibodies, have previously been described in MS. We performed this study to further explore the possibility of retinal autoimmunity in MS. METHODS: Thirty-four patients with clinically definite MS and thirty-seven healthy controls were recruited. All patients and controls had standard electroretinographic (ERG) testing done, as well as a brightflash ERG protocol to isolate rod photoreceptor function. Patient and control sera were analyzed for the presence of antiretinal antibodies using Western blot techniques. RESULTS: We found statistically significant differences between MS patients and controls in four ERG parameters. In the MS group, implicit times of the rod-cone b-wave response, cone b-wave response, and rod photoreceptor response were increased. The amplitudes of the photopic oscillatory potentials were reduced in the MS group. Patients with the highest titres of retinal autoantibodies had delayed rod-cone b-wave implicit times and diminished photopic oscillatory potential amplitudes. CONCLUSIONS: We report ERG evidence of retinal dysfunction in patients with MS. We also report the first use of the brightflash ERG protocol in MS, which demonstrated rod photoreceptor dysfunction. Patients with the highest antiretinal antibody titres had abnormal ERG recordings. Retinal autoimmunity is a possible explanation for these observed ERG abnormalities in MS patients.
BACKGROUND:Multiple sclerosis (MS) has been associated with inflammation of the uveal tract, suggesting an immunological link between the uvea and central nervous system (CNS) in this disease. The retina is embryologically derived from the CNS, and it is conceivable that retinal antigens may also be recognized by the immune system in MS. Electroretinographic abnormalities, as well as retinal autoantibodies, have previously been described in MS. We performed this study to further explore the possibility of retinal autoimmunity in MS. METHODS: Thirty-four patients with clinically definite MS and thirty-seven healthy controls were recruited. All patients and controls had standard electroretinographic (ERG) testing done, as well as a brightflash ERG protocol to isolate rod photoreceptor function. Patient and control sera were analyzed for the presence of antiretinal antibodies using Western blot techniques. RESULTS: We found statistically significant differences between MS patients and controls in four ERG parameters. In the MS group, implicit times of the rod-cone b-wave response, cone b-wave response, and rod photoreceptor response were increased. The amplitudes of the photopic oscillatory potentials were reduced in the MS group. Patients with the highest titres of retinal autoantibodies had delayed rod-cone b-wave implicit times and diminished photopic oscillatory potential amplitudes. CONCLUSIONS: We report ERG evidence of retinal dysfunction in patients with MS. We also report the first use of the brightflash ERG protocol in MS, which demonstrated rod photoreceptor dysfunction. Patients with the highest antiretinal antibody titres had abnormal ERG recordings. Retinal autoimmunity is a possible explanation for these observed ERG abnormalities in MS patients.
Authors: Richard G Weleber; Robert C Watzke; William T Shults; Karmen M Trzupek; John R Heckenlively; Robert A Egan; Grazyna Adamus Journal: Am J Ophthalmol Date: 2005-05 Impact factor: 5.258
Authors: S A Vinores; M Küchle; N L Derevjanik; J D Henderer; J Mahlow; W R Green; P A Campochiaro Journal: Histol Histopathol Date: 1995-10 Impact factor: 2.303
Authors: Wojciech A Gorczyca; Maria Ejma; Danuta Witkowska; Marta Misiuk-Hojło; Marianna Kuropatwa; Małgorzata Mulak; Stanisław Szymaniec Journal: Ophthalmic Res Date: 2004 Mar-Apr Impact factor: 2.892
Authors: Michaela A Seigo; Elias S Sotirchos; Scott Newsome; Aleksandra Babiarz; Christopher Eckstein; E'tona Ford; Jonathan D Oakley; Stephanie B Syc; Teresa C Frohman; John N Ratchford; Laura J Balcer; Elliot M Frohman; Peter A Calabresi; Shiv Saidha Journal: J Neurol Date: 2012-03-15 Impact factor: 4.849
Authors: Farzin Forooghian; Ian M Macdonald; John R Heckenlively; Elise Héon; Lynn K Gordon; John J Hooks; Barbara Detrick; Robert B Nussenblatt Journal: Am J Ophthalmol Date: 2008-07-30 Impact factor: 5.258
Authors: Shiv Saidha; Elias S Sotirchos; Jiwon Oh; Stephanie B Syc; Michaela A Seigo; Navid Shiee; Chistopher Eckstein; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Teresa C Frohman; Scott Newsome; John N Ratchford; Laura J Balcer; Dzung L Pham; Ciprian M Crainiceanu; Elliot M Frohman; Daniel S Reich; Peter A Calabresi Journal: JAMA Neurol Date: 2013-01 Impact factor: 18.302
Authors: Shiv Saidha; Elias S Sotirchos; Mohamed A Ibrahim; Ciprian M Crainiceanu; Jeffrey M Gelfand; Yasir J Sepah; John N Ratchford; Jiwon Oh; Michaela A Seigo; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Ari J Green; Quan D Nguyen; Peter A Calabresi Journal: Lancet Neurol Date: 2012-10-04 Impact factor: 44.182
Authors: Megha Kaushik; Chen Yu Wang; Michael H Barnett; Raymond Garrick; John Parratt; Stuart L Graham; Prema Sriram; Con Yiannikas; Alexandr Klistorner Journal: PLoS One Date: 2013-10-03 Impact factor: 3.240
Authors: Prema Sriram; Chenyu Wang; Con Yiannikas; Raymond Garrick; Michael Barnett; John Parratt; Stuart L Graham; Hemamalini Arvind; Alexander Klistorner Journal: PLoS One Date: 2014-08-28 Impact factor: 3.240